Medicare Part D specialty drugs are high-cost medications used to treat complex conditions such as cancer, rheumatoid arthritis, multiple sclerosis, and hepatitis C. Specialty drugs are typically in Tier 5 with the highest cost-sharing. The $2,000 out-of-pocket cap (effective 2025) significantly reduces costs for specialty drug users.
Key Points
- Specialty drugs: high-cost medications for complex conditions
- Typically in Tier 5 with highest cost-sharing
- Conditions: cancer, rheumatoid arthritis, MS, hepatitis C
- $2,000 OOP cap (effective 2025): significantly reduces costs for specialty drug users
- An independent agent can compare Part D plans based on your specialty medications